Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2Not yet recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Gastrointestinal 6Thoracic 3Genitourinary 3Breast 3Head & Neck 2CNS 2Tumor-Agnostic 1Lymphoid 1

Conditions

Breast Neoplasms 2Breast Cancer Female 1

Interventions

Cyclophosphamide 423Trastuzumab 414Paclitaxel 375Docetaxel 314Capecitabine 266Letrozole 262Carboplatin 257Doxorubicin 213Tamoxifen 184Fulvestrant 176Epirubicin 176Radiotherapy 171Anastrozole 164pembrolizumab 152pertuzumab 147Surveys and Questionnaires 146Exercise 142exemestane 128Vinorelbine 127palbociclib 124Bevacizumab 123Magnetic Resonance Spectroscopy 120Blood Specimen Collection 120Drug Therapy 106Albumin-Bound Paclitaxel 105Gemcitabine 99130-nm albumin-bound paclitaxel 98pyrotinib 92eribulin 90Biopsy 88

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Drug Delivery Systems × Breast × Clear all
NCT07487844 2026-03-23

Pulsed Electric Field Ablation for Metastatic Breast Cancer

University of California, San Francisco

Phase NA Not yet recruiting
20 enrolled
Breast

Breast Neoplasms

NCT04257799 2022-06-22

Lumpectomy Specimen Margin Evaluation With Tomography and Structured Light Imaging

Dartmouth-Hitchcock Medical Center

Completed
100 enrolled
Breast

Breast Cancer Female

NCT02690805 2021-04-19

Predicting Neoadjuvant Chemotherapy Response by Using a Combined MRI and Scinti-Mammography (MRI-SMM) System

University of California, Irvine

Completed
16 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡